Stock listing

BOATS:QSI Quantum-Si Incorporated Stock

US listing (BOATS) of Quantum-Si Incorporated · home listing NASDAQ:QSI

Follow Quantum-Si Incorporated into a list and get an email when it puts out news.

Home listing price · NASDAQ:QSI

$0.909 USD -0.161 (-15.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:QSI

Past year -26.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.892 – $1.040 USDNov 20, 2026
Volume
7.80M sharesNov 20, 2026
Market cap
$180.8M USDAt the close on Nov 20, 2026 · price × 198.9M shares outstanding
52-week range
$0.690 – $1.810 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$8.60M USDMedian day 5.36M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Quantum-Si Incorporated logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:QSI · Home$0.909 USD-0.161 (-15.0%)7,801,382$1.020$1.040$0.892$1.070Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:QSI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.909-0.161-15.0%$1.020$1.040$0.8927,801,382
$1.070+0.060+5.9%$1.145$1.210$1.05010,474,160
$1.010-0.050-4.7%$1.060$1.080$0.9925,352,378
$1.060-0.090-7.8%$1.100$1.110$1.0405,312,296
$1.150-0.070-5.7%$1.230$1.230$1.1403,536,152
$1.220-0.050-3.9%$1.173$1.250$1.1605,467,821
$1.270-0.010-0.8%$1.348$1.450$1.2406,848,954
$1.280-0.090-6.6%$1.330$1.390$1.2355,450,664
$1.370+0.040+3.0%$1.360$1.380$1.3025,572,636
$1.330+0.160+13.7%$1.180$1.450$1.1808,203,148
$1.170-0.120-9.3%$1.270$1.275$1.0806,685,167
$1.290-0.010-0.8%$1.310$1.330$1.2106,305,474
$1.300+0.040+3.2%$1.270$1.340$1.2414,551,363
$1.260-0.200-13.7%$1.490$1.500$1.2308,091,403
$1.460-0.290-16.6%$1.565$1.600$1.4059,872,279
$1.750+0.030+1.7%$1.681$1.810$1.6608,495,392
$1.720+0.070+4.2%$1.630$1.730$1.5909,949,577
$1.650+0.190+13.0%$1.500$1.750$1.49516,461,938
$1.460+0.060+4.3%$1.420$1.480$1.36010,265,376
$1.400+0.250+21.7%$1.155$1.420$1.15011,414,800
$1.150-0.080-6.5%$1.170$1.210$1.1453,572,200
$1.230+0.070+6.0%$1.160$1.230$1.1603,422,700
$1.160+0.070+6.4%$1.060$1.200$1.0406,172,600
$1.090-0.030-2.7%$1.145$1.150$1.0108,714,000
$1.120-0.190-14.5%$1.330$1.330$1.1007,690,600
$1.310-0.080-5.8%$1.350$1.390$1.2409,269,400
$1.390-0.020-1.4%$1.340$1.440$1.3305,364,900
$1.410+0.050+3.7%$1.345$1.460$1.3106,239,600
$1.360-0.170-11.1%$1.475$1.475$1.34010,356,400
$1.530+0.310+25.4%$1.260$1.660$1.25840,903,900
$1.220-0.060-4.7%$1.290$1.300$1.2005,851,500
$1.280+0.060+4.9%$1.170$1.310$1.0908,037,000
$1.220-0.060-4.7%$1.290$1.410$1.1908,703,200
$1.280-0.270-17.4%$1.525$1.530$1.26019,185,000
$1.550+0.120+8.4%$1.385$1.550$1.17018,774,100
$1.430+0.360+33.6%$1.200$1.480$1.15033,063,400
$1.070+0.112+11.7%$0.960$1.120$0.96013,838,800
$0.958+0.163+20.5%$0.805$1.030$0.80523,007,100
$0.795-0.039-4.7%$0.825$0.834$0.7951,562,300
$0.834+0.049+6.2%$0.794$0.840$0.7762,593,500
$0.785+0.026+3.4%$0.750$0.799$0.7431,593,300
$0.759-0.026-3.3%$0.790$0.805$0.7521,476,500
$0.785+0.029+3.8%$0.760$0.792$0.7512,429,900
$0.756+0.011+1.5%$0.759$0.766$0.7501,122,800
$0.745-0.025-3.2%$0.790$0.802$0.7401,708,600
$0.770+0.040+5.5%$0.750$0.796$0.7502,823,600
$0.730+0.010+1.4%$0.721$0.753$0.721909,700
$0.720-0.005-0.7%$0.720$0.741$0.7201,164,700
$0.725-0.015-2.0%$0.729$0.748$0.7201,387,900
$0.740+0.001+0.1%$0.739$0.755$0.7391,069,100
$0.739-0.011-1.5%$0.750$0.755$0.7251,712,500
$0.750-0.010-1.3%$0.760$0.775$0.7461,441,900
$0.760-0.006-0.8%$0.767$0.790$0.7601,049,000
$0.766+0.005+0.7%$0.760$0.774$0.760897,300
$0.7610.0000.0%$0.767$0.786$0.760980,000
$0.761+0.004+0.5%$0.759$0.785$0.7501,615,600
$0.757-0.009-1.2%$0.750$0.777$0.7501,503,700
$0.766-0.014-1.8%$0.779$0.780$0.7631,133,200
$0.780-0.023-2.9%$0.822$0.822$0.7702,412,700
$0.803+0.012+1.5%$0.791$0.834$0.7901,373,600
$0.791-0.056-6.6%$0.850$0.855$0.7902,662,900
$0.847+0.078+10.1%$0.789$0.859$0.7824,366,300
$0.769-0.066-7.9%$0.800$0.830$0.7523,853,800
$0.835+0.055+7.1%$0.785$0.931$0.7807,825,100
$0.780+0.010+1.3%$0.767$0.810$0.7673,233,600
Ticker
BOATS:QSI
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Quantum-Si Incorporated news

Quantum-Si Incorporated on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
28 in the last 12 months · 151 in all · newest Nov 18, 2026 · oldest 2021
Calls
22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
Decks
14 decks · latest Sep 29, 2026

Where Quantum-Si Incorporated is listed

ListingExchangeCountryCurrency
NASDAQ:QSI · Home listingNASDAQUnited StatesUSD
BOATS:QSI · This pageBOATSUnited StatesUSD

Valuation

EV/sales 63.3× against a median of 3.8×: the highest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$80.11M USD
P/E
Loss
EV/sales
63.3×
EV/EBITDA
Negative EBITDA
Price/book
1.1×
Gross margin
34.9%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
3.19

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Quantum-Si Incorporated · NASDAQ:QSIUS$180.8MUS$80.11Mn/a63.3×n/a1.1×n/a0.0×3.19
Shanghai Rendu Biotechnology Co., Ltd. Class A · SSE:688193US$216.7MUS$100.3M64.7×4.2×n/a1.6×13.9%0.0×n/a
Median Technologies · EURONEXT:ALMDTUS$214.8MUS$176.5Mn/a6.9×n/an/a−145.8%n/an/a
Tomocube, Inc. · KRX:475960US$208.3MUS$187.2Mn/a16.6×n/a7.4×−16.1%0.0×n/a
Guangzhou LBP Medicine Science & Technology Co., Ltd. Class A · SSE:688393US$195.9MUS$151.2Mn/a2.8×n/a1.2×−9.2%0.0×n/a
Dishman Carbogen Amcis Ltd. · NSE:DCALUS$195.5MUS$195.5M26.6×0.8×4.2×0.3×3.0%0.0×n/a
Tarsons Products Limited · NSE:TARSONSUS$174.2MUS$174.2M146×3.7×13.5×2.5×2.5%0.0×n/a
AVE Science & Technology Co., Ltd. Class A · SSE:688067US$170.2MUS$138.2M33.8×3.9×n/a2.1×14.3%0.0×n/a
Binex Co., Ltd · KRX:053030US$162.2MUS$182.2Mn/a1.6×n/a1.4×−18.6%0.4×n/a
Boditech Med, Inc. · KRX:206640US$152.0MUS$120.9M7.9×0.9×4.4×0.8×14.8%0.0×n/a
Genovis AB · OMXSTO:GENOUS$150.3MUS$142.9M74.9×10.8×41.7×5.0×15.1%0.3×n/a
Median of the othersUS$184.9MUS$162.7M49.2×3.8×9.0×1.6×2.8%0.0×

Forecasts

2 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
2.27 USD · Analysts' mean
EPS, year to Dec 2026
-0.40 · 1 analyst
Revenue, year to Dec 2026
1.05M · 3 analysts

Team and board

Officers

OfficerRole
Jeff HawkinsPresident and Chief Executive Officer
Jeff KeyesChief Financial Officer
Beth PeraltaVice President, Human Resources
Ryan MiranovichVice President, Legal

Board

DirectorRole
Charles KummethChairman of the Board
Gloria SheynkmanChair, Scientific Advisory Board
Jonathan M. RothbergChairman of the Board
Amir JafriDirector
Brigid A. MakesDirector
Jack KennyDirector
Kevin RakinDirector
Paula DowdyDirector
Ruth FattoriDirector
Scott MendelDirector

Events

Calls

CallWhenStatus
Quantum-Si (NASDAQ:QSI) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2026 Earnings CallThu, Aug 13, 2026 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q1 2026 Earnings CallThu, May 07, 2026 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q4 2025 Earnings CallTue, Mar 03, 2026 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2025 Earnings CallTue, Aug 05, 2025 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q1 2025 Earnings CallThu, May 15, 2025 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q4 2024 Earnings CallMon, Mar 03, 2025 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q3 2024 Earnings CallTue, Nov 12, 2024 · 8:00 AM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2024 Earnings CallWed, Aug 07, 2024 · 4:30 PM ETReplay
All 22 calls
CallWhenStatus
Quantum-Si (NASDAQ:QSI) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q4 2023 Earnings CallThu, Feb 29, 2024 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2023 Earnings CallMon, Aug 07, 2023 · 8:30 AM ETReplay
Quantum-Si (NASDAQ:QSI) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q4 2022 Earnings CallMon, Mar 06, 2023 · 8:30 AM ETReplay
Quantum-Si (NASDAQ:QSI) Q3 2022 Earnings CallMon, Nov 07, 2022 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q1 2022 Earnings CallMon, May 09, 2022 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q4 2021 Earnings CallMon, Feb 28, 2022 · 4:30 PM ETReplay
Quantum-Si (NASDAQ:QSI) Q3 2021 Earnings CallThu, Nov 11, 2021 · 8:30 AM ETReplay
Quantum-Si (NASDAQ:QSI) Q2 2021 Earnings CallMon, Aug 16, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+13.7%
Q2 2026Aug 13, 2026 · After close−6.3%
Q1 2026May 7, 2026 · After close−7.5%
Q4 2025Mar 3, 2026−2.5%
Q3 2025Nov 5, 2025 · After close−8.3%
Q2 2025Aug 5, 2025 · After close−4.9%
Q1 2025May 15, 2025 · After close0.0%
Q4 2024Feb 26, 2025 · After close−9.4%
Q3 2024Nov 12, 2024 · Before open−22.4%
Q2 2024Aug 7, 2024 · After close+3.4%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−7.1%
Q4 2023Feb 29, 2024 · After close+10.8%
Q3 2023Nov 9, 2023 · After close+6.8%
Q2 2023Aug 7, 2023 · Before open−32.1%
Q1 2023May 11, 2023 · After close−8.4%
Q4 2022Mar 6, 2023 · Before open−13.0%
Q3 2022Nov 7, 2022 · After close+2.0%
Q2 2022Aug 8, 2022 · After close−9.3%
Q1 2022May 9, 2022 · After close−3.4%
Q4 2021Feb 28, 2022 · After close+13.5%

Open Events

Decks

DeckKindSlidesDate
World HUPO 2026Conference21 slidesSep 29, 2026
Investor Presentation (December 2025)Investor deck23 slidesDec 29, 2025
Investor Day (November 2025)Investor day79 slidesNov 20, 2025
Investor Day (November 2025)Investor day79 slidesNov 19, 2025
Investor Presentation (August 2025)Investor deck26 slidesAug 8, 2025
Investor Presentation (April 2025)Investor deck28 slidesApr 10, 2025
Investor Day (November 2024)Investor day78 slidesNov 21, 2024
Investor Presentation (August 2024)Investor deck24 slidesAug 13, 2024
Investor Presentation (June 2024)Investor deck23 slidesJun 25, 2024
Investor Presentation (April 2024)Investor deck23 slidesApr 9, 2024
All 14 decks
DeckKindSlidesDate
Investor Presentation (March 2022)Investor deck27 slidesMar 8, 2022
Investor Presentation (September 2021)Investor deck17 slidesSep 29, 2021
Investor Presentation (June 2021)Investor deck16 slidesJun 15, 2021
SPAC Merger (February 2021)SPAC merger29 slidesFeb 18, 2021

Open Decks

Financings

RaiseDate
Registered direct offering of shares of common stock (and common stock equivalents)
Announced: about US$50M · US$1.67 a share · A.G.P./Alliance Global Partners
Dealers: A.G.P./Alliance Global Partners (lead)
Use of proceeds: Working capital and general corporate purposes
Jul 4, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as HighCape Capital Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Sep 3, 2020.

Price
US$10.00 a unit
Units offered
10,000,000 units
Offering size
US$100 million
Underwriters' option
Up to 1,500,000 more units
Listing
CAPAU on the Nasdaq Capital Market
Underwriter
Cantor
Units delivered
On or about Sep 9, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceJul 2, 2020
Filed publiclyAug 3, 2020
Amended twiceNewest Aug 31, 2020
Shares registered with an exchangeSep 2, 2020
Declared effective by the SECSep 3, 2020
Final prospectus, with the priceSep 4, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Sep 4, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue2.44M3.06M1.08M0000
Cost of revenue1.28M1.46M594.0K00894.0K
Gross profit1.15M1.60M488.0K00-894.0K
Research and development53.8M59.6M67.0M72.1M46.6M27.6M28.1M
Selling, general and administrative44.8M50.5M44.6M42.3M50.3M9.14M7.88M
Operating income-116.1M-108.6M-111.2M-123.8M-96.9M-36.7M-36.6M
Depreciation and amortization4.45M4.60M4.16M2.58M1.04M894.0K780.0K
EBITDA-111.6M-104.0M-107.0M-121.3M-95.9M-35.8M-35.8M
Interest expense005.00K9.00K0
Income before tax-101.3M-101.0M-96.0M-132.4M-95.0M-36.6M-35.8M
Income tax58.0K56.0K00000
Net income-101.3M-101.0M-96.0M-132.4M-95.0M-36.6M-35.8M
Earnings per share, basic-0.51-0.71-0.68-0.95-1.19-6.84-6.95
Earnings per share, diluted-0.51-0.71-0.68-0.95-1.19-6.84-6.95

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents21.6M49.2M133.9M84.3M35.8M36.9M32.9M
Short-term investments141.3M160.4M123.9M267.0M435.5M0
Receivables561.0K1.33M368.0K0872.0K550.0K826.0K
Inventory3.20M4.07M3.94M0-872.0K
Current assets175.9M218.0M266.3M358.2M477.2M37.9M33.9M
Property, plant and equipment13.2M16.0M16.3M16.8M8.91M2.00M2.55M
Goodwill09.48M0
Total assets245.6M247.9M298.3M391.5M503.2M40.6M37.4M
Accounts payable1.62M1.93M1.77M3.90M3.39M1.33M869.0K
Current liabilities23.0M18.2M11.6M15.7M11.5M2.75M1.93M
Long-term debt1.75M
Total debt4.17M12.9M15.3M17.4M8.08M1.75M
Total liabilities25.4M32.5M26.6M32.8M26.2M4.50M1.93M
Shareholders' equity220.2M215.4M271.6M358.7M477.0M-159.7M-125.1M
Shares outstanding197.8M143.2M141.3M139.3M79.6M5.38M136.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-94.7M-87.8M-94.0M-90.6M-66.8M-32.6M-30.7M
Capital spending-2.52M-4.58M-4.51M-10.7M-5.76M-461.0K-1.24M
Free cash flow-97.2M-92.4M-98.5M-101.3M-72.6M-33.0M-31.9M
Cash from investing-28.3M-32.7M143.4M137.2M-450.9M-461.0K-1.24M
Cash from financing95.4M35.9M149.0K1.91M516.6M37.0M18.2M
Share buybacks2.76M5.61M116.8M
Change in cash-27.6M-84.6M49.5M48.5M-1.13M3.98M-13.7M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 18, 2026Current reportSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
8-K · Current reportOct 15, 2026Current reportSEC
8-K · Current reportOct 8, 2026Current reportSEC
8-K · Current reportSep 28, 2026Current reportSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
144 · Notice of proposed saleSep 23, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleSep 23, 2026Other filingsSEC
144 · Notice of proposed saleSep 23, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 28, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2026Big-stake noticeSEC
8-K · Current reportJul 24, 2026Current reportSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
144 · Notice of proposed saleJun 24, 2026Other filingsSEC
144 · Notice of proposed saleJun 24, 2026Other filingsSEC
144 · Notice of proposed saleJun 24, 2026Other filingsSEC
144 · Notice of proposed saleJun 24, 2026Other filingsSEC
8-K · Current reportJun 24, 2026Material contractSEC
25-NSEJun 10, 2026Other filingsSEC
SD · Specialized disclosureMay 22, 2026ESG reportSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
8-K · Current reportMay 15, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
144 · Notice of proposed saleApr 22, 2026Other filingsSEC
144 · Notice of proposed saleApr 22, 2026Other filingsSEC
ARS · Annual report to shareholdersApr 1, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2026Meeting noticeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
144 · Notice of proposed saleMar 24, 2026Other filingsSEC
144 · Notice of proposed saleMar 24, 2026Other filingsSEC
144 · Notice of proposed saleMar 24, 2026Other filingsSEC
144 · Notice of proposed saleMar 24, 2026Other filingsSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 3, 2026Offer documentSEC
10-K · Annual reportMar 3, 2026Annual reportSEC
8-K · Current reportMar 3, 2026ResultsSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
8-K · Current reportDec 29, 2025Current reportSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 22, 2025Other filingsSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 22, 2025Other filingsSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 22, 2025Other filingsSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
144 · Notice of proposed saleDec 22, 2025Other filingsSEC
8-K · Current reportNov 20, 2025Current reportSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
424B3 · ProspectusOct 29, 2025Offer documentSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
144 · Notice of proposed saleOct 20, 2025Other filingsSEC
4 · Change in ownershipOct 17, 2025Insider tradeSEC
144 · Notice of proposed saleOct 16, 2025Other filingsSEC
S-3/A · Registration statement, amendedOct 9, 2025Offer documentSEC
8-K · Current reportSep 29, 2025Material contractSEC
S-3 · Registration statementSep 26, 2025Offer documentSEC
8-K · Current reportSep 26, 2025Material contractSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 11, 2025Big-stake noticeSEC
8-K · Current reportAug 8, 2025Current reportSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 29, 2025Big-stake noticeSEC
8-K · Current reportJul 7, 2025Material contractSEC
424B5 · ProspectusJul 7, 2025Offer documentSEC
424B5 · ProspectusJul 7, 2025Offer documentSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 6, 2025Big-stake noticeSEC
SD · Specialized disclosureMay 22, 2025ESG reportSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
8-K · Current reportMay 19, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportMay 15, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
8-K · Current reportApr 10, 2025Current reportSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
ARS · Annual report to shareholdersMar 20, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 20, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 20, 2025Meeting noticeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 3, 2025Offer documentSEC
10-K · Annual reportMar 3, 2025Annual reportSEC
8-K · Current reportMar 3, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 10, 2025Big-stake noticeSEC
8-K · Current reportJan 6, 2025Material contractSEC
424B5 · ProspectusJan 6, 2025Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 31, 2024Big-stake noticeSEC
4 · Change in ownershipDec 31, 2024Insider tradeSEC
144 · Notice of proposed saleDec 27, 2024Other filingsSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
8-K · Current reportDec 11, 2024Material contractSEC
424B5 · ProspectusDec 11, 2024Offer documentSEC
8-K · Current reportDec 9, 2024Current reportSEC
8-K · Current reportNov 22, 2024Current reportSEC
8-K · Current reportNov 20, 2024Current reportSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K/A · Current report, amendedNov 12, 2024Current reportSEC
8-K · Current reportNov 12, 2024ResultsSEC
8-K · Current reportNov 8, 2024Current reportSEC
4 · Change in ownershipSep 25, 2024Insider tradeSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 18, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedSep 17, 2024Big-stake noticeSEC
8-K · Current reportAug 27, 2024Management or board changeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
8-K · Current reportAug 12, 2024Current reportSEC
3 · Initial statement of ownershipAug 12, 2024Insider tradeSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedJun 28, 2024Big-stake noticeSEC
4 · Change in ownershipJun 25, 2024Insider tradeSEC
8-K · Current reportJun 25, 2024Current reportSEC
144 · Notice of proposed saleJun 21, 2024Other filingsSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
8-K · Current reportJun 7, 2024Current reportSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 30, 2024Insider tradeSEC
8-K · Current reportMay 30, 2024Management or board changeSEC
144 · Notice of proposed saleMay 24, 2024Other filingsSEC
8-K · Current reportMay 24, 2024Current reportSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
8-K · Current reportMay 17, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
DEFR14AApr 29, 2024Meeting noticeSEC
8-K · Current reportApr 9, 2024Current reportSEC
ARS · Annual report to shareholdersApr 1, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2024Meeting noticeSEC
4 · Change in ownershipMar 25, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 25, 2024Insider tradeSEC
PRE 14A · Preliminary proxy statementMar 22, 2024Meeting noticeSEC

This page holds 200 of 474 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Quantum-Si Incorporated’s releases · as of Nov 13, 2026

Common shares
198,946,412
Fully diluted
199,441,747

Fully diluted

LineSharesAs of
Common shares198,946,412
Options and RSUs495,335Nov 13, 2026

Warrants and options

Lot
RSUs · expiry not stated

Share count over time

CountShares
Nov 22, 2026198,946,412

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Vanguard9.23M4.6%US$9.87M−69,753Nov 16, 2026
ARK7.39M3.7%US$7.91M+225KNov 13, 2026
BlackRock4.79M2.4%US$5.12M−436KNov 13, 2026
Sumitomo Mitsui Trust Group, Inc.3.71M1.9%US$3.97M−172KOct 29, 2026
Amova Asset Management Americas, Inc.3.71M1.9%US$3.94M−172KNov 13, 2026
Geode Capital2.13M1.1%US$2.28M−111KNov 6, 2026
Susquehanna1.88M0.94%US$2.01M+759KNov 16, 2026
UBS1.35M0.68%US$1.45M−1.21MNov 10, 2026
Renaissance Technologies1.2M0.60%US$1.28M+643KNov 12, 2026
State Street791K0.40%US$846K−99,800Nov 12, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Fosun International Ltd744K0.37%US$796KNo changeNov 10, 2026
Hrt Financial LP486K0.24%US$519K+392KNov 13, 2026
Invesco478K0.24%US$511K+33,592Nov 12, 2026
Northern Trust427K0.21%US$457K−23,152Nov 16, 2026
IQ EQ FUND MANAGEMENT (IRELAND) Ltd392K0.20%US$420K+71,001Nov 13, 2026
Knollwood Investment Advisory, LLC300K0.15%US$321KNo changeNov 13, 2026
IMC-Chicago, LLC300K0.15%US$320K+13,763Nov 5, 2026
Goldman Sachs256K0.13%US$274K−220KNov 16, 2026
Simplex Trading, LLC241K0.12%US$258K+75,735Nov 4, 2026
Bridgeway Capital Management, LLC203K0.10%US$217K−3,358Nov 16, 2026
Empowered Funds, LLC197K0.10%US$210KNewNov 13, 2026
WINTON GROUP Ltd155K0.08%US$166K+79,347Nov 12, 2026
Schonfeld Strategic Advisors LLC154K0.08%US$165K+143KNov 16, 2026
Shay Capital LLC151K0.08%US$161KNo changeNov 16, 2026
AQR Capital Management LLC139K0.07%US$149K−2.21MNov 16, 2026
Verdence Capital Advisors LLC133K0.07%US$143K−25,000Oct 26, 2026
Jane Street128K0.06%US$137K−2.01MNov 12, 2026
Millennium111K0.06%US$119K−3.02MNov 16, 2026
AlphaCore Capital LLC88,8500.04%US$95,070−518Nov 4, 2026
Barclays86,9740.04%US$93,062−119KNov 6, 2026
Bank of America86,8660.04%US$92,946+27,281Nov 16, 2026
Hollencrest Capital Management85,0000.04%US$90,950+19,989Nov 13, 2026
Fidelity80,6990.04%US$86,348−43,068Nov 10, 2026
Group One Trading LLC78,0360.04%US$83,499−29,437Nov 10, 2026
JTC Employer Solutions Trustee Ltd77,7870.04%US$83,000No changeNov 9, 2026
Jump Financial, LLC67,8110.03%US$72,558NewNov 13, 2026
Morgan Stanley64,5900.03%US$69,113−259KNov 13, 2026
Kovack Advisors, Inc.60,0000.03%US$64,200+29,000Nov 13, 2026
Jones Financial Companies Lllp58,2000.03%US$48,539−42,283Nov 13, 2026
Two Sigma55,0590.03%US$58,913NewNov 16, 2026
Mariner, LLC49,4510.02%US$52,913−108KNov 10, 2026
Green Alpha Advisors, LLC47,3970.02%US$50,715+1,476Oct 8, 2026
Stratos Wealth Advisors, LLC40,0360.02%US$42,839No changeNov 13, 2026
Cambridge Investment Research Advisors, Inc.37,8090.02%US$40,000−37,809Nov 2, 2026
Red Wave Investments LLC37,0000.02%US$39,590No changeNov 10, 2026
China Universal Asset Management Co., Ltd.36,3000.02%US$34,779+4,816Oct 27, 2026
SBI Securities Co., Ltd.36,1300.02%US$38,659+3,121Oct 21, 2026
Captrust Financial Advisors33,2570.02%US$35,585−39,871Nov 12, 2026
Sanctuary Advisors, LLC31,1880.02%US$33,371−10,209Nov 13, 2026
IPG Investment Advisors LLC30,8640.02%US$33,024No changeOct 29, 2026

This page holds 50 of 110 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
ARK Genomic Revolution ETF6.76M3.4%US$4.82M−168KJul 31, 2026
Vanguard Total Stock Market Index Fund5.35M2.7%US$4.74M+479KJun 30, 2026
Vanguard Extended Market Index Fund1.99M1.00%US$1.76M−7,275Jun 30, 2026
iShares Biotechnology ETF1.2M0.60%US$1.06M−25,671Jun 30, 2026
Fidelity Extended Market Index Fund907K0.46%US$1.08M+402KMay 31, 2026
Vanguard Russell 2000 Index Fund862K0.43%US$1.03M+85,041May 31, 2026
Vanguard Health Care Index Fund540K0.27%US$642K+46,049May 31, 2026
iShares Core S&P Total U.S. Stock Market ETF431K0.22%US$382K+10,336Jun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF425K0.21%US$303K+4,488Jul 31, 2026
Fidelity Total Market Index Fund328K0.16%US$391KNo changeMay 31, 2026
All 39 holders
HolderSharesOf the companyValueChangeAs of
Fidelity Series Total Market Index Fund271K0.14%US$322K+5,807May 31, 2026
Ultra-Small Company Market Fund200K0.10%US$177K−55,000Jun 30, 2026
Vanguard Russell 2000 Value Index Fund133K0.07%US$158K+16,989May 31, 2026
Fidelity Nasdaq Composite Index Fund111K0.06%US$132KNo changeMay 31, 2026
Fidelity ZERO Total Market Index Fund106K0.05%US$75,633+24,954Jul 31, 2026
Vanguard Balanced Index Fund83,5590.04%US$73,950No changeJun 30, 2026
Schwab Total Stock Market Index Fund76,6450.04%US$54,602No changeJul 31, 2026
Small Cap Index Fund73,3660.04%US$87,306No changeMay 31, 2026
Vanguard Institutional Total Stock Market Index Fund68,0800.03%US$60,251No changeJun 30, 2026
Bridge Builder Small/Mid Cap Value Fund67,4330.03%US$59,678No changeJun 30, 2026
Fidelity ZERO Extended Market Index Fund62,4010.03%US$44,454−4,026Jul 31, 2026
Goldman Sachs Absolute Return Tracker Fund58,5390.03%US$51,807+22,329Jun 30, 2026
Fidelity Flex Small Cap Index Fund31,1490.02%US$22,191+2,800Jul 31, 2026
Siit Extended Market Index Fund21,5000.01%US$25,585No changeMay 31, 2026
Victory Extended Market Index Fund19,630<0.01%US$13,984−178Jul 31, 2026
VIP Extended Market Index Portfolio13,270<0.01%US$11,744+1,429Jun 30, 2026
Vanguard Russell 3000 Index Fund12,899<0.01%US$15,350No changeMay 31, 2026
Invesco Nasdaq Biotechnology ETF10,304<0.01%US$12,262−629May 31, 2026
ProShares Russell 2000 High Income ETF7,954<0.01%US$9,465+1,148May 31, 2026
ProShares Ultra Nasdaq Biotechnology7,230<0.01%US$8,604−1,800May 31, 2026
ProShares UltraPro Russell20006,285<0.01%US$7,479−3,402May 31, 2026
ProShares Ultra Russell20006,220<0.01%US$7,402−3,504May 31, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF4,310<0.01%US$5,129−238May 31, 2026
Destinations Small-Mid Cap Equity Fund3,978<0.01%US$4,734No changeMay 31, 2026
VIP Total Market Index Portfolio3,910<0.01%US$3,460No changeJun 30, 2026
Total Stock Market Index Trust3,255<0.01%US$2,881No changeJun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND892<0.01%US$635+39Jul 31, 2026
ProShares Hedge Replication ETF158<0.01%US$188−3May 31, 2026
ProShares Russell 2000 Dynamic Buffer ETF49<0.01%US$58+1May 31, 2026

Insider trades

InsiderTradeSharesPriceValueDate
LaPointe Christian
Officer: GC & Corp. Secretary
Sale4,721USD 0.76US$3,588Sep 22, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale2,493USD 0.76US$1,895Sep 22, 2026
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale9,709USD 0.76US$7,379Sep 22, 2026
LaPointe Christian
Officer: GC & Corp. Secretary
Sale9,795USD 0.76US$7,444Sep 21, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale5,172USD 0.76US$3,931Sep 21, 2026
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale20,143USD 0.76US$15,309Sep 21, 2026
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale11,311USD 0.90US$10,180Jun 23, 2026
Vieceli John S.
Officer: Chief Product Officer
Sale15,112USD 0.90US$13,601Jun 23, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale4,117USD 0.90US$3,705Jun 23, 2026
LaPointe Christian
Officer: GC & Corp. Secretary
Sale7,794USD 0.90US$7,015Jun 23, 2026
All 18 trades
InsiderTradeSharesPriceValueDate
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale11,310USD 0.96US$10,858Jun 22, 2026
Vieceli John S.
Officer: Chief Product Officer
Sale15,111USD 0.96US$14,507Jun 22, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale4,116USD 0.96US$3,951Jun 22, 2026
LaPointe Christian
Officer: GC & Corp. Secretary
Sale7,794USD 0.96US$7,482Jun 22, 2026
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale83,712USD 1.00US$83,712Apr 21, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale37,381USD 1.00US$37,381Apr 21, 2026
Hawkins Jeffrey Alan
Director, Officer: President & CEO
Sale83,712USD 1.01US$84,549Apr 20, 2026
Keyes Jeffry R.
Officer: Chief Financial Officer
Sale37,382USD 1.01US$37,756Apr 20, 2026

Big stakes

HolderStakeSharesDate
ROTHBERG JONATHAN M7.20%14.4MAug 26, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Marijn E Dekkers
Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Sep 16, 2021 – Jun 12, 2024 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 11, 2021 · Past); GE Aerospace (Director · Jun 12, 2012 – Apr 2, 2018 · Past); Biogen Inc. (Director · May 31, 2007 – Jun 3, 2009 · Past); Thermo Fisher Scientific Inc (Chief Executive Officer, Director · Jan 7, 2006 – Aug 17, 2009 · Past)
Director · Jun 10, 2021 – May 11, 2022 · Past
Brigid A. Makes
Other companies: Elutia, Inc. (Board Member · Since at least Oct 7, 2020); Vivani Medical, Inc. (Chief Financial Officer · Aug 30, 2022 – May 12, 2025 · Past); Definium Therapeutics, Inc. (Director · Jan 1, 2022 – Jun 1, 2022 · Past); AGA Medical Holdings Inc (CFO · Oct 20, 2009 – Nov 18, 2010 · Past); Bioject Medical Technologies Inc (Director · Sep 14, 2006 – Jun 5, 2009 · Past)
Director · Since at least Jun 10, 2021
Jim Tananbaum
Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Alumis Inc. (Director · Since at least Jun 27, 2024); Pardes Biosciences Inc (President and CEO, Director · Feb 16, 2021 – Aug 31, 2023 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Disc Medicine, Inc. (Director · Aug 11, 2020 – Oct 4, 2021 · Past)
Director · Jun 10, 2021 – Jun 10, 2021 · Past
Charles Kummeth
Other companies: Orthofix Medical Inc. (Director · Since at least Dec 14, 2023); Gentherm Inc (Member of the Board · Since at least Aug 1, 2018); Bio-Techne Corp (Chief Executive Officer, Director · Apr 1, 2013 – Aug 15, 2023 · Past); Sparton Corporation (Director · Nov 11, 2011 – Mar 4, 2019 · Past)
Chairman of the Board · Since at least May 27, 2024
Jack Kenny
Other companies: NeoGenomics, Inc. (Director · Since at least Jan 1, 2026); OraSure Technologies, Inc. (Director · Since at least Sep 6, 2024); Biomerica, Inc. (Director · Aug 28, 2023 – Dec 13, 2023 · Past); Meridian Bioscience Inc (Chief Executive Officer, Director · Oct 9, 2017 – Jan 31, 2023 · Past)
Director · Since at least May 19, 2023
Scott Mendel
Other companies: Quanterix Corporation (Director · Since at least Jul 8, 2025); Akoya Biosciences Inc (Director · Since at least Jun 11, 2021); GenMark Diagnostics Inc (President & CEO, Director · May 13, 2014 – Apr 22, 2021 · Past); Active Network Inc (Chief Financial Officer · May 24, 2011 – Nov 15, 2013 · Past)
Director · Since at least May 11, 2023
Claudia N. Drayton
Other companies: Brookdale Senior Living Inc. (Director · Since at least Jun 18, 2024); 3D Systems Corporation (Director · Since at least Dec 1, 2021); Nuwellis, Inc. (Chief Financial Officer · Jan 5, 2015 – Jan 22, 2021 · Past)
Chief Financial Officer · Jun 10, 2021 – Mar 15, 2023 · Past
Kevin Rakin
Other companies: Elutia, Inc. (Chairman · Since at least Oct 7, 2020); Oramed Pharmaceuticals Inc. (Director · Aug 30, 2016 – Mar 21, 2022 · Past); Ocugen, Inc. (Director · Dec 2, 2014 – Feb 8, 2019 · Past)
Director · Since at least Sep 3, 2020
Matthew Zuga
Other companies: Acumen Pharmaceuticals, Inc. (Chief Financial Officer & Chief Business Officer · Since at least Jun 30, 2021); Elutia, Inc. (Director · Since at least Oct 7, 2020); TELA Bio, Inc. (Director · Nov 7, 2019 – Nov 8, 2019 · Past)
Director · Sep 3, 2020 – Sep 3, 2020 · Past
Jonathan Rothberg
Other companies: Hyperfine, Inc. (Director · Since at least Dec 22, 2021); Butterfly Network, Inc. (Director · Since at least Feb 12, 2021)
Director · Since at least Jun 10, 2021
All 33 people
PersonSeat
Ruth Fattori
Other companies: Hyperfine, Inc. (Director · Since at least Dec 22, 2021); PepsiCo, Inc. (EVP, HR & Chief HR Officer · Oct 1, 2017 – Mar 1, 2018 · Past)
Director · Since at least Jun 10, 2021
Antony Loebel
Other companies: Seaport Therapeutics, Inc. (Chief Medical Officer and President of Clinical Development · Since at least Apr 30, 2026)
Director · Sep 3, 2020 – Sep 3, 2020 · Past
David Colpman
Other companies: Elutia, Inc. (Board Member · Since at least Oct 20, 2022)
Director · Sep 3, 2020 – Sep 3, 2020 · Past
Jeffrey Alan Hawkins
Other companies: GenMark Diagnostics Inc (SVP, Global Marketing & PM · Nov 3, 2010 – Sep 11, 2015 · Past)
President & CEO, Director · Since at least Oct 10, 2022
Jeffry R. Keyes
Other companies: CNS Pharmaceuticals, Inc. (Director · Since at least Nov 7, 2019)
Chief Financial Officer · Since at least May 15, 2023
Michael Mina
Other companies: Invivyd, Inc. (Chief Medical Officer and Chief Epidemiologist · Since Mar 5, 2026)
Director · Jun 10, 2021 – May 12, 2023 · Past
Robert Taub
Other companies: Omrix Biopharmaceuticals Inc (Chief Executive Officer, Director · Apr 11, 2006 – Nov 23, 2008 · Past)
Director · Sep 3, 2020 – Sep 3, 2020 · Past
Vikram Bajaj
Other companies: Disc Medicine, Inc. (Director · Aug 11, 2020 – Aug 11, 2020 · Past)
Director · Jun 15, 2022 – Jun 16, 2022 · Past
Amir JafriDirector · Since at least Sep 22, 2023
Beth PeraltaVice President, Human Resources · Since at least Nov 4, 2026
Christian LaPointeGC & Corp. Secretary · Since at least Jun 10, 2021
Gloria SheynkmanChair, Scientific Advisory Board · Since at least Apr 15, 2026
Grace JohnstonChief Commercial Officer · Dec 21, 2022 – Jun 21, 2024 · Past
Jeff HawkinsPresident and Chief Executive Officer · Since at least Sep 23, 2026
Jeff KeyesChief Financial Officer · Since at least Oct 16, 2026
John S VieceliChief Product Officer · Since at least Aug 2, 2024
John VIII StarkChief Executive Officer, Director · Jun 10, 2021 – Jan 10, 2022 · Past
Matthew DyerChief Business Officer · Jun 10, 2021 – Jun 13, 2022 · Past
Michael P McKennaEVP, Product Development & Ops · Jun 10, 2021 – Mar 15, 2023 · Past
Patrick SchneiderPresident and COO · May 9, 2022 – Mar 15, 2023 · Past
Paula DowdyDirector · Since at least Mar 21, 2024
Ryan MiranovichVice President, Legal · Since at least Nov 5, 2026
Todd C BennettChief Commercial Officer · Since at least Sep 17, 2024

Open People

Log in to ask 6ix AI your own questions about Quantum-Si Incorporated.